ADR Ontology |
ADR Term |
Focal nodular hyperplasia |
ADR ID |
BADD_A08093 |
ADR Hierarchy |
|
Description |
Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen. [MeSH] |
MedDRA Code |
10052285 |
MeSH ID |
D020518
|
ADR Severity Grade (FAERS)
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
Synonym |
Focal nodular hyperplasia | Hepatic nodular hyperplasia | Focal Nodular Hyperplasia | Focal Nodular Hyperplasias | Hyperplasias, Focal Nodular | Hyperplasia, Focal Nodular |
|
|
ADR Related Proteins |
Protein Name |
UniProt AC |
TTD Target ID |
Not Available | Not Available | Not Available |
|
Drugs Leading to the ADR |
Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | BADD_D00195 | Azathioprine | 0.001436% | | BADD_D01281 | Levonorgestrel | 0.007296% | | BADD_D01633 | Oxaliplatin | 0.001598% | |
The 1th Page 1
Total 1 Pages
|
|